1. Saito C, Minami Y, Arai K, Haruki S, Yagishita Y, Jujo K et al. Prevalence, clinical characteristics, and outcome of atrial functional mitral regurgitation in hospitalized heart failure patients with atrial fibrillation. Journal of Cardiology. 2018;72(4):292–9. DOI: 10.1016/j.jjcc.2018.04.002
2. Kagiyama N, Mondillo S, Yoshida K, Mandoli GE, Cameli M. Subtypes of Atrial Functional Mitral Regurgitation: Imaging Insights Into Their Mechanisms and Therapeutic Implications. JACC: Cardiovascular Imaging. 2020;13(3):820–35. DOI: 10.1016/j.jcmg.2019.01.040
3. Zoghbi WA, Levine RA, Flachskampf F, Grayburn P, Gillam L, Leipsic J et al. Atrial Functional Mitral Regurgitation. JACC: Cardiovascular Imaging. 2022;15(11):1870–82. DOI: 10.1016/j.jcmg.2022.08.016
4. Tamargo M, Obokata M, Reddy YNV, Pislaru SV, Lin G, Egbe AC et al. Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction. European Journal of Heart Failure. 2020;22(3):489–98. DOI: 10.1002/ejhf.1699
5. Deferm S, Bertrand PB, Verbrugge FH, Verhaert D, Rega F, Thomas JD et al. Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week. Journal of the American College of Cardiology. 2019;73(19):2465–76. DOI: 10.1016/j.jacc.2019.02.061
6. Галявич А.С., Терещенко С.Н., Ускач Т.М., Агеев Ф.Т., Аронов Д.М., Арутюнов Г.П. и др. Хроническая сердечная недостаточность. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(11):251-349. DOI: 10.15829/1560-4071-2024-6162
7. Riccardi M, Cikes M, Adamo M, Pagnesi M, Lombardi CM, Solomon SD et al. Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management. Journal of Cardiac Failure. 2024;30(7):929–39. DOI: 10.1016/j.cardfail.2024.02.024
8. Hagendorff A, Knebel F, Helfen A, Stöbe S, Haghi D, Ruf T et al. Echocardiographic assessment of mitral regurgitation: discussion of practical and methodologic aspects of severity quantification to improve diagnostic conclusiveness. Clinical Research in Cardiology. 2021;110(11):1704–33. DOI: 10.1007/s00392-021-01841-y
9. Сафарова А.Ф., Кобалава Ж.Д., Адам С.Б., Тимофеева Т.М. Влияние предсердной функциональной митральной регургитации на клинические исходы у пациентов с сердечной недостаточностью с сохраненной фракцией выброса и фибрилляцией предсердий на фоне оптимальной медикаментозной терапии. Терапевтический архив. 2025;97(8):618-26. DOI: 10.26442/00403660.2025.08.203337
10. Murata A, Kaneko T, Amano M, Sato Y, Ohno Y, Obokata M et al. Qualitative and quantitative assessment of atrial functional mitral regurgitation: analysis from the REVEAL-AFMR registry. European Heart Journal - Cardiovascular Imaging. 2025;26(2):299–306. DOI: 10.1093/ehjci/jeae288
11. Kajimoto K, Sato N, Takano T, on behalf of the investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry. Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction. European Journal of Heart Failure. 2016;18(8):1051–9. DOI: 10.1002/ejhf.562
12. Kagami K, Kagiyama N, Kaneko T, Harada T, Sato K, Amano M et al. Heart failure with preserved ejection fraction in atrial functional mitral regurgitation – Insight from the REVEAL-AFMR. International Journal of Cardiology. 2025;422:132958. DOI: 10.1016/j.ijcard.2025.132958
13. Abe Y, Akamatsu K, Ito K, Matsumura Y, Shimeno K, Naruko T et al. Prevalence and Prognostic Significance of Functional Mitral and Tricuspid Regurgitation Despite Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation Patients. Circulation Journal. 2018;82(5):1451–8. DOI: 10.1253/circj.CJ-17-1334
14. Eckardt L, Sehner S, Suling A, Borof K, Breithardt G, Crijns H et al. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial. European Heart Journal. 2022;43(40):4127–44. DOI: 10.1093/eurheartj/ehac471
15. Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. New England Journal of Medicine. 2020;383(14):1305–16. DOI: 10.1056/NEJMoa2019422
16. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. New England Journal of Medicine. 2018;378(5):417–27. DOI: 10.1056/NEJMoa1707855
17. Benito-González T, Carrasco-Chinchilla F, Estévez-Loureiro R, Pascual I, Arzamendi D, Garrote-Coloma C et al. Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation. International Journal of Cardiology. 2021;345:29–35. DOI: 10.1016/j.ijcard.2021.09.056
18. Gu G, Wu J, Gao X, Liu M, Jin C, Xu Y. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta‐analysis. Clinical Cardiology. 2022;45(7):786–93. DOI: 10.1002/clc.23841
19. Саидова М.А., Макеев М.И., Кучин И.В., Комлев А.Е., Имаев Т.Э., Акчурин Р.С. Транскатетерная пластика митрального клапана «край-в-край» у пациентов с тяжелой митральной недостаточностью. (Первый российский опыт однолетнего наблюдения). Кардиологический вестник. 2023;18(4):33–40. DOI: 10.17116/Cardiobulletin20231804133